AdvanSix vs Avient
ASIX and AVNT side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ASIX and AVNT compare
Avient is the larger company, worth 9.8 times as much as AdvanSix ($4.0B against $411M).
AdvanSix grew revenue faster over the last twelve months (3.0% versus 2.4% for Avient).
Avient keeps more of each dollar of sales as profit, with a net margin of 5.1% compared with −1.1% at AdvanSix.
Both pay dividends: AdvanSix yields 4.2% and Avient 2.5%.
Avient scores higher on the StockData Score (12 against 11 for AdvanSix), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ASIX | AVNT |
|---|---|---|
| Size and price | ||
| Market cap | $411M | $4.0B |
| Share price | $15.24 | $43.97 |
| Change, 1 year | −5.9% | 45.8% |
| Change, 5 years | −67.5% | −23.4% |
| Beta (5Y) | −1.46 | 0.83 |
| Employees | 1,410 | 9,000 |
| StockData Score | ||
| Total score | 11 | 12 (better) |
| Valuation score | 3 (better) | 2 |
| Growth score | 0 | 2 (better) |
| Performance score | 1 | 2 (better) |
| Health score | 5 (better) | 2 |
| Dividend score | 2 | 4 (better) |
| Valuation | ||
| P/E | – | 23.8× |
| P/S | 0.3× (better) | 1.2× |
| P/B | 0.5× (better) | 1.7× |
| EV/EBITDA | – | 10.9× |
| P/FCF | – | 21.1× |
| FCF yield | −6.3% | 4.7% (better) |
| Fair value | $36.40 | $45.17 |
| Margin of safety | 58.1% (better) | 2.6% |
| Growth | ||
| Revenue growth (TTM) | 3.0% (better) | 2.4% |
| Revenue growth, 5Y average | 5.6% | 8.0% (better) |
| Net income growth (TTM) | −123% | 43.0% (better) |
| EPS growth (TTM) | −123% | 43.4% (better) |
| EPS growth, 5Y average | 1.9% (better) | −9.3% |
| Profitability | ||
| Gross margin | 5.6% | 31.7% (better) |
| Operating margin | – | 9.5% |
| Net margin | −1.1% | 5.1% (better) |
| FCF margin | −1.7% | 5.7% (better) |
| Return on equity | −2.2% | 7.1% (better) |
| Return on invested capital | – | 6.1% |
| Financial health | ||
| Debt / equity | 0.00 | 0.77 (better) |
| Net debt / EBITDA | – | 2.87 |
| Current ratio | 1.28 | 1.90 (better) |
| Altman Z-score | 1.82 (better) | 1.55 |
| Piotroski F-score | 7 (better) | 6 |
| Dividends and buybacks | ||
| Dividend yield | 4.2% (better) | 2.5% |
| Payout ratio | – | 58.7% |
| Years of dividend growth | – | 15 |
| Dividend growth, 5Y average | – | 5.8% |
| Buyback yield | 0.30% | – |
| Shareholder yield | 4.5% (better) | 2.5% |
| Ownership | ||
| Held by institutions | 91.7% | 105% |
| Held by insiders | 4.6% | 0.83% |
| Short interest, % of float | 2.1% | 4.7% |
Go deeper
- ASIX stock overview
- ASIX income statement
- ASIX valuation and score
- AVNT stock overview
- AVNT income statement
- AVNT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.